<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zdor</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы здоровья и экологии</journal-title><trans-title-group xml:lang="en"><trans-title>Health and Ecology Issues</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2220-0967</issn><issn pub-type="epub">2708-6011</issn><publisher><publisher-name>Gomel State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.51523/2708-6011.2021-18-3-6</article-id><article-id custom-type="elpub" pub-id-type="custom">zdor-2032</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>Аналитическая оценка стационарного ведения пациентов с инфекцией COVID-19</article-title><trans-title-group xml:lang="en"><trans-title>Analytical assessment of hospital management of patients with COVID-19</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5579-750X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никифорова</surname><given-names>О. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikiforova</surname><given-names>O. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Никифорова Ольга Леонидовна, ассистент кафедры поликлинической терапии и общеврачебной практики </p><p>Гомель</p></bio><bio xml:lang="en"><p>Olga L. Nikiforova, Assistant Lecturer at the Department of Polyclinic Therapy and General Medical Practice </p><p>Gomel</p></bio><email xlink:type="simple">Nikiforova.O.L@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1706-0144</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Галиновская</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Galinovskaya</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Галиновская Наталья Викторовна, д.м.н., профессор, декан факультета повышения квалификации и переподготовки </p><p>Гомель</p></bio><bio xml:lang="en"><p>Natalya V. Galinovskaya, DMedSc, Professor, Dean of the Faculty of Professional Development and Retraining </p><p>Gomel</p></bio><email xlink:type="simple">stroke.ynt@tut.by</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5013-0415</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ковальчук</surname><given-names>П. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kovalchuk</surname><given-names>P. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ковальчук Петр Николаевич, к.м.н., доцент, доцент кафедры поликлинической терапии и общеврачебной практики </p><p>Гомель</p></bio><bio xml:lang="en"><p>Peter N. Kovalchuk, PhD (Med), Associate Professor, Associate Professor at the Department of Polyclinic Therapy and General Medical Practice </p><p>Gomel</p></bio><email xlink:type="simple">kovalchukgomel@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Гомельский государственный медицинский университет</institution></aff><aff xml:lang="en"><institution>Gomel State Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>30</day><month>09</month><year>2021</year></pub-date><volume>18</volume><issue>3</issue><fpage>47</fpage><lpage>56</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Никифорова О.Л., Галиновская Н.В., Ковальчук П.Н., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Никифорова О.Л., Галиновская Н.В., Ковальчук П.Н.</copyright-holder><copyright-holder xml:lang="en">Nikiforova O.L., Galinovskaya N.V., Kovalchuk P.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.gsmu.by/jour/article/view/2032">https://journal.gsmu.by/jour/article/view/2032</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования. Провести аналитическую оценку динамики состояния пациентов с инфекцией COVID-19 в условиях больничной организации здравоохранения с учетом коморбидных заболеваний.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Ретроспективно проанализированы 96 медицинских карт пациентов больничных организаций, заполненных в государственном учреждении здравоохранения «Гомельская городская клиническая больница № 3».</p></sec><sec><title>Результаты</title><p>Результаты. Медиана возраста для женщин, прошедших стационарное лечение по поводу пневмонии, ассоциированной с COVID-19, составила 58 лет [45; 66], мужчин — 58 лет [39; 64]. Все пациенты проходили клиническое обследование согласно временным протоколам. Наиболее частыми коморбидными заболеваниями у пациентов с инфекцией COVID-19 являлись: артериальная гипертензия, ишемическая болезнь сердца, неалкогольная жировая болезнь печени, сахарный диабет, хронический пиелонефрит, ожирение. Полиморбидность была выявлена у 49 % пациентов. У большинства пациентов пневмония, ассоциированная с инфекцией COVID-19, имела среднюю степень тяжести. (75 % от всех обследованных). У пациентов с легким течением пневмонии, ассоциированной с инфекцией COVID-19, соотношение нейтрофилов к лимфоцитам периферической крови составило 2,1, тогда как у пациентов с тяжелым течением — 8,82, что коррелировало с традиционными прогнозными показателями: уровнем С-реактивного белка, Д-димеров, лактатдегидрогеназы.</p></sec><sec><title>Заключение</title><p>Заключение. Соотношение нейтрофилов к лимфоцитам периферической крови является простым и доступным методом прогноза в отношении течения инфекции COVID-19 у коморбидных пациентов.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective. To conduct an analytical assessment of the dynamics of the state of patients with COVID-19 in the conditions of a clinical healthcare organization taking into account comorbid diseases.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. 96 in-patients` medical records kept in the state healthcare institution “Gomel City Clinical Hospital No.3” have been retrospectively analyzed.</p></sec><sec><title>Results</title><p>Results. The median age for women having undergone hospital treatment for pneumonia associated with COVID-19 was 58 years [45; 66], for men — 58 years [39; 64]. All the patients underwent a clinical examination according to temporary protocols. The most frequent comorbid diseases in the patients with COVID-19 were: arterial hypertension, ischemic heart disease, non-alcoholic liver disease, diabetes mellitus, chronic pyelonephritis, obesity. Polymorbidity was revealed in 49 % of the patients. Most patients had moderately severe pneumonia associated with COVID-19 (75 % of all the surveyed patients). In the patients with a mild course of pneumonia associated with COVID-19, the neutrophil-to-lymphocyte ratioin the peripheral blood was 2.1, whereas in the patients with a severe course — 8.82, which correlated with traditional prognostic indicators — the levels of C-reactive protein, d-dimers, lactate dehydrogenase.</p></sec><sec><title>Conclusion</title><p>Conclusion. The neutrophil-to-lymphocyte ratio in the peripheral blood is a simple and affordable method of COVID-19 course prediction in comorbid patients.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>инфекция COVID-19</kwd><kwd>коморбидные заболевания</kwd><kwd>прогностический показатель</kwd></kwd-group><kwd-group xml:lang="en"><kwd>COVID-19</kwd><kwd>comorbid diseases</kwd><kwd>prognostic indicator</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Баздырев ЕД. Короновирусная инфекция – актуальная проблема XXI века. Комплексные проблемы сердечно-сосудистых заболеваний. 2020;9(2):6-16. DOI: https://doi.org/10.17802/2306-1278-2020-9-2-6-16</mixed-citation><mixed-citation xml:lang="en">Basdirev ED. Coronovirus infection is an actual problem of the XXI century. Complex problems of cardiovascular diseases. 2020;9(2):6-16. (In Russ.). DOI: https://doi.org/10.17802 / 2306-1278-2020-9-2-6-16</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Попович ЮГ, Рахимова РЖ, Ахметжанова ДО. COVID-19 – новая инфекция XXI века. Наука и здравоохранение. 2020;4(22):15-23. DOI: https://doi.org/10.34689/SH.2020.22.4.002</mixed-citation><mixed-citation xml:lang="en">Popovich YG, Rakhimova RJ, Akhmetzhanov DO. COVID-19 is a new XXI century infection. Science and healthcare. 2020;4(22):15-23. (In Russ.). DOI: https://doi.org/10.34689 / SH.2020.22.4.002</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">COVID-19 Map – Johns Hopkins Coronavirus Resource Center [date of access 2021 June 18]. Available from: https://coronavirus.jhu.edu/map.html</mixed-citation><mixed-citation xml:lang="en">COVID-19 Map – Johns Hopkins Coronavirus Resource Center [date of access 2021 June 18]. Available from: https://coronavirus.jhu.edu/map.html</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Nile SH, Nile A, Qiu J, Li L, Jia X, Kai G, COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine Growth Factor Rev. 2020;53:66-70. DOI: https://doi.org/10.1016/j.cytogfr.2020.05.002</mixed-citation><mixed-citation xml:lang="en">Nile SH, Nile A, Qiu J, Li L, Jia X, Kai G, COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine Growth Factor Rev. 2020;53:66-70. DOI: https://doi.org/10.1016/j.cytogfr.2020.05.002</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Sun Y, Dong Y, Wang L, Xie H, Li B, et al. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience. J Autoimmun. 2020;112:102473. DOI: https://doi.org/10.1016/j.jaut.2020.102473</mixed-citation><mixed-citation xml:lang="en">Sun Y, Dong Y, Wang L, Xie H, Li B, et al. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience. J Autoimmun. 2020;112:102473. DOI: https://doi.org/10.1016/j.jaut.2020.102473</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ripa M, Galli L, Poli A, Oltolini C, Spagnuolo V, et al. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect. 2021;27(3):451-457. DOI: https://doi.org/10.1016/j.cmi.2020.10.021</mixed-citation><mixed-citation xml:lang="en">Ripa M, Galli L, Poli A, Oltolini C, Spagnuolo V, et al. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect. 2021;27(3):451-457. DOI: https://doi.org/10.1016/j.cmi.2020.10.021</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Gallo Marin B, Aghagoli G, Lavine K, et al. Predictors of COVID-19 severity: A literature review. Rev Med Virol. 2021;31(1):1-10. DOI: https://doi.org/10.1002/rmv.2146</mixed-citation><mixed-citation xml:lang="en">Gallo Marin B, Aghagoli G, Lavine K, et al. Predictors of COVID-19 severity: A literature review. Rev Med Virol. 2021;31(1):1-10. DOI: https://doi.org/10.1002/rmv.2146</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rostami M, Mansouritorghabeh H, D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol. 2020;13(11):1265-1275. DOI: https://doi.org/10.1080/17474086.2020.1831383</mixed-citation><mixed-citation xml:lang="en">Rostami M, Mansouritorghabeh H, D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol. 2020;13(11):1265-1275. DOI: https://doi.org/10.1080/17474086.2020.1831383</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ковальчук ЛС. Синдром удлиненного интервала QT и его роль в возникновении сложных нарушений ритма сердца и внезапной смерти. Проблемы здоровья и экологии. 2016;(3):13-19. [дата обращения 2021 июнь 10]. Режим доступа: https://journal.gsmu.by/jour/article/view/1705</mixed-citation><mixed-citation xml:lang="en">Kovalchuk LS. Long QT syndrome and its role in THE development of severe heart rhythm disturbances and sudden death. Health and Ecology Issues. 2016;(3):13-19. [date of access 2021 June 10]. Available from: https://journal.gsmu.by/jour/article/view/1705 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Леонова МВ. Кардиотоксичность хлорохина и гидроксихлорохина при лечении инфекции COVID-19. Consilium Medicum. 2020;22(10):15-21. DOI: https://doi.org/10.26442/20751753.2020.10.200270</mixed-citation><mixed-citation xml:lang="en">Leonova MV. Сardiotoxicity of chloroquine and hydroxychloroquine in the treatment of COVID-19 infection. Consilium Medicum. 2020;22(10):15-21. (In Russ.). DOI: https://doi.org/10.26442/20751753.2020.10.200270</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Alkhatip AAAMM, Kamel MG, Hamza MK, Farag EM, Yassin HM, et al. The diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in COVID-19: a systematic review and meta-analysis. Expert Rev Mol Diagn. 2021;25;505-514. DOI: https://doi.org/10.1080/14737159.2021.1915773</mixed-citation><mixed-citation xml:lang="en">Alkhatip AAAMM, Kamel MG, Hamza MK, Farag EM, Yassin HM, et al. The diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in COVID-19: a systematic review and meta-analysis. Expert Rev Mol Diagn. 2021;25;505-514. DOI: https://doi.org/10.1080/14737159.2021.1915773</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Li X, Liu C, Mao Z, Xiao M, Wang L, et al. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Crit Care. 2020;24(1):647. DOI: https://doi.org/10.1186/s13054-020-03374-8</mixed-citation><mixed-citation xml:lang="en">Li X, Liu C, Mao Z, Xiao M, Wang L, et al. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Crit Care. 2020;24(1):647. DOI: https://doi.org/10.1186/s13054-020-03374-8</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, Luo M, Chen L, Zhao Y. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81(1):e6-e12. DOI: https://doi.org/10.1016/j.jinf.2020.04.002</mixed-citation><mixed-citation xml:lang="en">Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, Luo M, Chen L, Zhao Y. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81(1):e6-e12. DOI: https://doi.org/10.1016/j.jinf.2020.04.002</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Shang W, Dong J, Ren Y, Tian M, Li W, Hu J, Li Y. The value of clinical parameters in predicting the severity of COVID-19. J Med Virol. 2020;92(10):2188-2192. DOI: https://doi.org/10.1002/jmv.26031</mixed-citation><mixed-citation xml:lang="en">Shang W, Dong J, Ren Y, Tian M, Li W, Hu J, Li Y. The value of clinical parameters in predicting the severity of COVID-19. J Med Virol. 2020;92(10):2188-2192. DOI: https://doi.org/10.1002/jmv.26031</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Han MA, Kim JH, Diagnostic X-Ray Exposure and Thyroid Cancer Risk: Systematic Review and Meta-Analysis. Thyroid. 2018;28(2):220-228. DOI: https://doi.org/10.1089/thy.2017.0159</mixed-citation><mixed-citation xml:lang="en">Han MA, Kim JH, Diagnostic X-Ray Exposure and Thyroid Cancer Risk: Systematic Review and Meta-Analysis. Thyroid. 2018;28(2):220-228. DOI: https://doi.org/10.1089/thy.2017.0159</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
